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Research fairness initiative sets out to improve North-South partnerships
Carel IJsselmuiden outlines its basic elements, rationale and vision
Glaudina Loots offers a view from South Africa on how it might help in practice
Research infrastructure isn't just about buildings and equipment. It's also
about policy frameworks, legislation and generally creating a conducive
environment for research — what Carel IJsselmuiden calls “the soft side of
how to get science going”. 
IJsselmuiden is director of COHRED, a Geneva-based international NGO
that focuses on supporting low- and middle-income countries to improve
their research capacity. As part of that, COHRED has set up the Research
Fairness Initiative (RFI): a mechanism designed to ‘strongly encourage’
institutions to report the policies
(http://www.scidev.net/global/governance/policy/) and practices they
follow to ensure fairness in the collaborative research they undertake. 
SciDev.Net spoke with IJsselmuiden about the mechanism and its aims
after a discussion among RFI supporters in Brussels
(http://www.scidev.net/global/policy/scidev-net-at-large/tool-targets-
fairness-deficit-research.html) last month. 
There we also spoke with Glaudina Loots, Director of Health Innovation at
the South African Department of Science and Technology, in an audio
interview that discusses some of the practical dimensions of
implementing this tool.  
Dr. IJsselmuiden, what is the research fairness initiative?
The research fairness initiative is an attempt to create a first reporting
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The three areas of
fairness
1. Fairness of opportunity or
what happens before
research starts
2. Fairness of process or
relationship issues during
research
3. Fairness of benefit-cost and
outcome sharing or the
results
format that would allow institutions that take part in global collaborative
research — whether health or otherwise — to specify how they deal in key
issues with those partnerships. These might be overhead costs, or sharing
of intellectual property rights
(http://www.scidev.net/global/enterprise/intellectual-property/) or decision
making on how to modify studies. 
  
We've been having a global consultation over a
year and a half and we came up with this RFI that
defines three areas of fairness. One is fairness of
opportunity — more or less what happens before
research
(http://www.scidev.net/global/enterprise/rd/)
starts. The second is fairness of process —
relationship issues during research. And the third
is fairness of benefit-cost and outcome sharing —
the results at the end of research. For each we've
defined five practical topics that have come up in
all workshops, and then three indicators in each
of those. 
So an RFI report would be an annual or biannual
report that institutions produce that outlines how
they deal with partnerships. The purpose is to
create transparency, to enable institutions to
actually say what they are doing and where they
want to improve — that is the reporting part.
Secondly, it is to start picking up what others are doing in terms of
capacity building, system infrastructure, benefits that they leave behind —
so it is also a learning platform. 
 
The RFI has also been referred to as an index. Can you clarify the
difference between initiative and index?
  
It is subtle but very important. The initiative started off as a COHRED
fairness index. The underlying part of an index is that you have criteria
that you can measure, and by which you say the measure is right or
wrong. That presumes you actually know what is right. 
  
Now let me give you an example. Overhead costs are one of the most
important areas of building sustainable research infrastructure, and also
the most contentious. But the cost to build an institution, or to build
telecommunications, varies tremendously. Some donors allow zero per
cent. Others do [fund overheads], like the European Union now allows 25%,
and the NIH (US National Institutes of Health) will allow 60-67% or more
on top of the grant. So the question is what is right — is 0% right, is 30%
right? We don't know. Part of moving from an index to an initiative is to
say, let's at least start reporting what is common practice, and then maybe
in a few years' time some of those criteria may become more like an index. 
 
I noticed the initiative has a large number of indicators, I think about
45? This could be a deterrent for reporting, especially at a time when
countries are implementing the SDGs. Is that something you're
concerned about?
  
The answer is yes. In the various
global consultations people bring that
message across regularly. Particularly
the pharmaceutical industry mentions
an example like the Access to
Medicines index, which puts a
tremendous reporting load and
administrative load. We've also heard
this from non-profit organisations and
donors. So the cost-benefit ratio needs
to be important. 
  
Having said that, many of those
indicators are actually indicators of
good management practice. And that
gives a different perspective. If, for
example, one of the indicators asks
‘does your institution have a research management office’, you can say yes
— surely any self-respecting research institution that wants to receive


















to document what you have and then to specify where you want to go in
the next two years should be a normal management practice. So yes, we
are concerned to reduce the load as much as possible. The message is that
RFI is not a new externally imported reporting standard on top of SDGs
and on top of whatever else is required — actually it is a report that you
should be writing as an internal report for your own management and
performance improvement. 
  
Is that kind of reporting not being done currently as part of the donor
funding process?
  
If you look at the literature that describes how research happens in
collaboration — particularly between high- and low-income countries —
there is a tremendous amount of literature of imbalance in financial
means, in power of decision making, in access to the products and the
intellectual property (IP) rights. There are endless amounts of articles on
how people were robbed off their IP, how data and specimens are forced to
leave a country. We all say 'that is bad', and there are people who take it
very seriously, but there is no framework within which you can grow to
understand what would be an appropriate or fair standard. So that's one
thing the RFI wants to do. The second thing is that based on those
experiences there are very committed people and institutions that have
developed internal standards. But that is often not communicated. The RFI
helps to increase compliance with those guidelines and those tools that do
exist. I think that is one of the big virtues. 
 
There was some scepticism at yesterday’s conference (https://caast-
net-plus.org/object/event/1519) as to the mandatory nature of the
tool. Have you had any reflections on that?
  
We need to get our message right. RFI is a voluntary, self-reporting system
- there's nothing mandatory about it. If I tell you, however, that if you
could choose between two institutions — one that produces
conscientiously an RFI report and reflects on how it wants to do business
in partnership, and another that doesn't — the choice is inevitably going to
be for those who actually produce a report. So if your report says ‘our
ethics system isn't quite working’, that is not a sign of weakness, it is a
sign of where extra support could increase the capability. So no it's not
mandatory. The remark that is important is that it has to be applied by a
sufficient number of people to work. I also want to put the word
scepticism in place: I think the big message from yesterday's meeting was,
'we all want it'. The question is no longer whether or not [to take it
forward], but how.
You might also like
Fairness is important, but hard to pin down (/global/health/scidev-
net-at-large/fairness-index-health-hard-to-pin-down.html?
_src=related articles)
Guide aims to shift research benefits in North-South …
(/global/cooperation/news/guide-aims-to-shift-research-benefits-in-
north-south-collaborations.html?_src=related articles)
Ailing Global Forum for Health Research joins COHRED
(/global/health/news/ailing-global-forum-for-health-research-joins-
cohred.html?_src=related articles)
There were also calls by the EU representatives for some more clarity and
focus. How do you plan to take this on board in your next steps? 
  
I think the logical next step is to pilot this in a series of institutions, and to
write reports. So that we can see how it practically functions within
government departments or within research institutions and the private
sector. And to keep having workshops like this. I expect that what we now
call a Beta version will be tweaked, not substantially changed, and that
this version can run for 2-4 years perhaps. Then we will learn as people
write it and use it. And so I would imagine that in 50 years' time, with
thousands of users, it would be a different tool than what we have today. 
 
Do you have a vision for those 50 years? Yesterday you mentioned the
evidence-based system of medicine and you seemed to make a
parallel between the two.
  
I'm really impressed, across the globe and across meetings, that there
seems to be a wish for researchers to be part of a movement that creates
more fairness and fairness of access to the benefits of research to the





world. I think there is a sense — but there is no tool, there is no
framework, there is no common standard. And for me the parallel that I
drew was very much about when I started medical training: evidence-
based medicine was very much in its infancy and most was expert driven
— so one professor would say something totally opposite from the other,
and sentences would always start with "in my experience". And that
sentence, "in my experience", is what we see now in capacity building and
research systems. In clinical medicine that sentence has been totally
replaced by evidence-based medicine. And it is based on getting the data
on the table. RFI is going to do that. In 20 years' time, the evidence base on
how to build research infrastructure support into project granting will be
way different from what it is now. 
  
Q&As are edited for length and clarity. 
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